<DOC>
	<DOCNO>NCT02961634</DOCNO>
	<brief_summary>Single-center study , single blind , comparative objective evaluate efficacy safety investigational product adjunct treatment onychomycosis improvement 90 day Â± 2 day .</brief_summary>
	<brief_title>Study Efficacy Safety Comparative Use Investigational Product Adjuvant Treatment Onychomycosis</brief_title>
	<detailed_description />
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Ciclopirox</mesh_term>
	<criteria>Volunteers sex ; Volunteers age 1865 year ; Volunteers onychomycosis confirm positive direct mycological nail hand foot ; Agreement comply test procedure attend clinic day time certain application / assessment ; Understand , consent sign Instrument Consent Clarified . Pregnancy risk pregnancy / lactation ; Use antiinflammatory / immunosuppressive drug ( last 30 day study ) ; Concomitant nail pathology ( psoriasis , lichen planus , etc . ) ; Systemic condition may compromise growth nail ( vascular disease , diabetes , etc . ) ; Irritation History similar product investigational product ; Treatment antifungal medication prior study ( 12 week systemic medication topical medication four week ) ; Other condition consider investigator physician reasonable disqualification individual 's participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>onychomycosis</keyword>
	<keyword>nail</keyword>
</DOC>